-
<![CDATA[Episode 150: Rethinking Parkinson’s Care: Prevention, Equity, and Access to Treatment]]>
19 Sep 2025 14:39 GMT
… of The Parkinson Plan, and medical advisor for the Parkinson’s … – Consequences of delayed or unavailable levodopa treatment for patients worldwide
2:40 … – Lessons from global HIV drug distribution for equitable levodopa delivery
7:00 …
-
Dear Doctor: What are long-term effects on liver, kidneys from taking Parkinson’s medications?
17 Sep 2025 15:53 GMT
… . The medicines that I have been prescribed are carbidopa/levodopa and … levodopa/carbidopa and amantadine are very frequently used for the treatment … new vision changes during treatment with this drug should prompt a visit …
-
Looking at a case of Parkinson's and its relation to dementia
17 Sep 2025 08:11 GMT
… . The medicines that I have been prescribed are carbidopa/levodopa and … kidneys be after taking these medicines for the rest of my …
-
Developing Targeted Treatments for Parkinson’s with AI Algorithms
10 Sep 2025 14:52 GMT
… through clinical observation. Doctors look for key motor … Trials
Clinical trials are essential for testing new treatments …
Improve consistency across trial sites
Even adjust … managing treatment, and it’s rarely straightforward. Medications like levodopa …
-
Natural Products from Chinese Medicine Targeting NF-κB Signaling: Emerging Therapeutic Avenues for Neurodegenerative Diseases
10 Sep 2025 15:22 GMT
… 140 Currently, levodopa is the primary clinical treatment for PD … traditional models in personalized medicine, drug screening, and ethical considerations … pathway. Appl Biochem Biotechnol. 2022;194(6):2448 … gut-brain axis. Acta Pharmaceutica Sinica B. 2021; …
-
Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease
09 Sep 2025 19:20 GMT
… biotechnology company developing its proprietary POZ Platform™ drug … poorly controlled by current treatments,” said Greg Bailey, … fluctuations (which includes levodopa-induced dyskinesia) and … completion dates for clinical trials, regulatory submission dates …
-
Medication Adherence in Parkinson’s Disease: Longitudinal Changes and the Influence of Depressive Symptoms
09 Sep 2025 05:59 GMT
… require long-term pharmaceutical treatment.7 However, adherence … for designing interventional trials. Measures of … counseling, psychotherapy, or antidepressant medications, should be integrated … Estimating Equation; LEDD, levodopa equivalent daily dose; MDS …
-
Anti-Parkinson's Drugs Global Markets to 2030 with AbbVie, Amneal Pharmaceuticals, Acadia Pharmaceuticals, Supernus Pharmaceuticals and Teva Pharmaceutical Dominating - ResearchAndMarkets.com
08 Sep 2025 17:07 GMT
… drugs (levodopa and carbidopa) are the gold standard of treatment. … medications. In February 2025, the FDA approved a second drug- … device combination product, Onapgo (apomorphine hydrochloride) from Supernus Pharmaceuticals …
-
Missing link could finally pinpoint exactly what causes Parkinson's... amid fears contagious virus is to blame
02 Sep 2025 14:56 GMT
…
Researchers from Northwestern Medicine analyzed the brains of … global neurology at Northwestern Medicine, said in a statement … accelerate research and treatment discovery.
Scientists analyzed … Levodopa (L-Dopa) is the gold standard and most effective treatment …
-
Supernus Pharmaceuticals to Participate in September Investor Conferences
27 Aug 2025 20:15 GMT
… About Supernus Pharmaceuticals, Inc. Supernus Pharmaceuticals is a … portfolio includes approved treatments for attention-deficit … (PD) patients receiving levodopa-based therapy, hypomobility … 's clinical trials, and projected expenditures; …